Evidence that cholesteryl ester and triglyceride accumulation in J774 macrophages induced by very low density lipoprotein subfractions occurs by different mechanisms.
The present investigations have examined the mechanism(s) whereby Sf 60-400 very low density lipoproteins (VLDL) from Type IV hypertriglyceridemic subjects cause cholesteryl ester and triglyceride accumulation in J774 macrophages. Both apolipoprotein (apo) E-poor and apoE-rich Type IV VLDL subfractions, isolated by heparin-Sepharose chromatography, were capable of enhancing cellular cholesterol and triglyceride content. The apoE-rich fraction was significantly more effective at inducing cholesterol esterification (P < 0.05) and accumulation of esterified cholesterol (P < 0.05), whereas both subfractions caused similar increases in cellular triglyceride content. Thus, the amount of VLDL-associated apoE determined the extent to which Type IV VLDL loaded J774 cells with cholesterol but not triglyceride. Two VLDL subfractions, Sf 60-400 and Sf 20-60, isolated from Type III subjects homozygous for apoE2, caused little or no effect on cellular esterified cholesterol content, whereas both fractions induced the same degree of cellular triglyceride accumulation as Type IV VLDL. Type IV VLDL-induced cholesteryl ester accumulation was blocked by an anti-apoE monoclonal antibody, known to block the binding of apoE to the LDL receptor; however, the increase in cellular triglyceride was unaffected. Therefore, VLDL-induced triglyceride accumulation in this cell line can occur without apoE-mediated uptake of intact VLDL particles. The addition of heparin to J774 cells resulted in a 6-fold increase in lipoprotein lipase (LPL) activity in the media, and significantly enhanced the ability of Type IV VLDL to induce cellular triglyceride accumulation (P < 0.01), but significantly decreased cellular cholesteryl ester content (P < 0.025). Finally, Sf 60-400 VLDL from two subjects homozygous for apoC-II deficiency failed to increase cellular lipid content. However, the addition of exogenous apoC-II to C-II-deficient VLDL resulted in significant increases of both triglyceride and esterified cholesterol in J774 cells. In the presence of apoC-II, the anti-apoE monoclonal antibody blocked the cellular cholesteryl ester increase induced by C-II-deficient VLDL, but had no effect on the increase in cellular triglyceride. Collectively, these experiments demonstrate that extracellular lipolysis of Sf 60-400 VLDL by LPL is required for cholesteryl ester and triglyceride accumulation in J774 macrophages. After interaction with cellular LPL, VLDL triglycerides are hydrolyzed. The resulting free fatty acids are readily taken up by the macrophage, and re-esterified into triglyceride. Lipolysis proceeds until apoE epitopes are exposed, allowing the triglyceride-depleted remnant, containing all the cholesteryl ester, to be taken up via an apoE-mediated process.
Department of Medicine, Robarts Research Institute, University of Western Ontario, London, Canada.
A J
AJ
Evans
C G
CG
Sawyez
B M
BM
Wolfe
P W
PW
Connelly
G F
GF
Maguire
M W
MW
Huff
D000818:Animals; D000911:Antibodies, Monoclonal; D001057:Apolipoproteins E / Q000276:immunology / Q000378:metabolism; D002460:Cell Line; D002788:Cholesterol Esters / Q000378:metabolism*; D006801:Humans; D006952:Hyperlipoproteinemia Type III / Q000378:metabolism; D006953:Hyperlipoproteinemia Type IV / Q000378:metabolism*; D008055:Lipids / Q000032:analysis; D008071:Lipoprotein Lipase / Q000032:analysis; D008079:Lipoproteins, VLDL / Q000302:isolation & purification / Q000378:metabolism*; D008264:Macrophages / Q000737:chemistry; D051379:Mice; D011973:Receptors, LDL / Q000378:metabolism; D014280:Triglycerides / Q000378:metabolism*
D000911:Antibodies, Monoclonal; D001057:Apolipoproteins E; D002788:Cholesterol Esters; D008055:Lipids; D008079:Lipoproteins, VLDL; D011973:Receptors, LDL; D014280:Triglycerides; D008071:Lipoprotein Lipase